In summary, our data suggest no confounding effect of medication, bacteriuria, onset of symptoms, date of admission, or kidney biopsy on the occurrence of leukocyturia in the PR3-ANCA GN subgroup. This evidence concerns the gene PRTN3 and ganglioneuroma.